Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

DAIICHI S : Notice on Details of the Share Options

07/12/2011 | 04:20am US/Eastern
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126 on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)


Date of Board of Directors resolution: June 27, 2011

React to this article
1d ago ONCOSEC MEDICAL : and Plexxikon Join Forces
2d ago RANBAXY LABORATORIES : Loses Bid To Block Endo And DRL From Launching Generic Ne..
3d ago DAIICHI SANKYO : Researchers at Daiichi Sankyo Release New Data on Veterinary Me..
3d ago RANBAXY LABORATORIES : sues US drug regulator for revoking approvals
3d ago RANBAXY LABORATORIES : sues FDA for revoking approvals
3d ago RANBAXY LABORATORIES : Sues usfda for revoking drug approvals
4d ago RANBAXY LABORATORIES : Files Complaint Against FDA Over Revocation of Tentative ..
4d ago Cci to take call on sun-ranbaxy deal this month
5d ago RANBAXY LABORATORIES : Bt500 rankings: india's most valuable top-500 companies -..
6d ago Sun ranbaxy merger may spill over to 2015
Duration : Period :
DAIICHI SANKYO COMPANY, LI Technical Analysis Chart | 4568 | JP3475350009 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes